211 related articles for article (PubMed ID: 16566422)
1. [Complete atrioventricular block during galantamine therapy].
Leentjens AF; Kragten JA
Ned Tijdschr Geneeskd; 2006 Mar; 150(10):563-6. PubMed ID: 16566422
[TBL] [Abstract][Full Text] [Related]
2. [Complete atrioventricular block during galantamine therapy].
Schölzel-Dorenbos CJ
Ned Tijdschr Geneeskd; 2006 Apr; 150(17):989-90; author reply 990. PubMed ID: 17225744
[No Abstract] [Full Text] [Related]
3. Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.
Isik AT; Bozoglu E; Naharci MI; Kilic S
Am J Geriatr Pharmacother; 2010 Oct; 8(5):454-9. PubMed ID: 21335298
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
[TBL] [Abstract][Full Text] [Related]
5. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
Chu LW; Yik PY; Mok W; Chung CP
Int J Clin Pract; 2007 Mar; 61(3):403-10. PubMed ID: 17313606
[TBL] [Abstract][Full Text] [Related]
6. [Galantamine: a novel cholinergic agent for Alzheimer's disease].
Olazarán J; García G
Neurologia; 2002 Oct; 17(8):429-36. PubMed ID: 12396973
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].
Schwalbe O; Wunderlich S; Kloft C
Med Monatsschr Pharm; 2006 Jun; 29(6):222-4. PubMed ID: 16792199
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients.
Senanarong V; Poungvarin N; Phanthumchinda K; Thavichachart N; Chankrachang S; Praditsuwan R; Nidhinandana S
J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S12-8. PubMed ID: 19562980
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
Schölzel-Dorenbos CJ;
Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
[TBL] [Abstract][Full Text] [Related]
11. [Observational study on safety, tolerability and effectiveness of galantamine in patients with mild to moderately severe Alzheimer's disease].
Blesa R; García Ribas G; Galdós L; Olascoaga J; Amer G; Marey López J; Barquero M; Marsall C; Ezpeleta D
Neurologia; 2006; 21(6):289-96. PubMed ID: 16799903
[TBL] [Abstract][Full Text] [Related]
12. [Bradycardia induced by galantamine].
Leclerc C; Genuit-Leclerc L; Citerne O
Ann Fr Anesth Reanim; 2008 Nov; 27(11):949-52. PubMed ID: 19008069
[TBL] [Abstract][Full Text] [Related]
13. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
Cossu G; Melis M; Melis G; Maccioni E; Putzu V; Catte O; Putzu PF
Mov Disord; 2004 Oct; 19(10):1243-4. PubMed ID: 15389998
[TBL] [Abstract][Full Text] [Related]
14. Use of rivastigmine or galantamine and risk of adverse cardiac events: a database study from the Netherlands.
Kröger E; Berkers M; Carmichael PH; Souverein P; van Marum R; Egberts T
Am J Geriatr Pharmacother; 2012 Dec; 10(6):373-80. PubMed ID: 23217530
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine.
López-Pousa S; Olmo JG; Franch JV; Estrada AT; Cors OS; Nierga IP; Gelada-Batlle E
Age Ageing; 2006 Jul; 35(4):365-71. PubMed ID: 16788079
[TBL] [Abstract][Full Text] [Related]
16. Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months.
Rockwood K; Dai D; Mitnitski A
Int J Geriatr Psychiatry; 2008 Feb; 23(2):207-14. PubMed ID: 17621382
[TBL] [Abstract][Full Text] [Related]
17. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
18. The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients.
Chankrachang S; Senanarong V; Poungvarin N; Phanthumchinda K; Tavichachart N; Praditsuwan R; Nidhinandana S
J Med Assoc Thai; 2008 Sep; 91(9):1343-9. PubMed ID: 18843862
[TBL] [Abstract][Full Text] [Related]
19. Galantamine in Alzheimer's disease.
Razay G; Wilcock GK
Expert Rev Neurother; 2008 Jan; 8(1):9-17. PubMed ID: 18088197
[TBL] [Abstract][Full Text] [Related]
20. Galantamine: use in Alzheimer's disease and related disorders.
Bullock R
Expert Rev Neurother; 2004 Mar; 4(2):153-63. PubMed ID: 15853556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]